Clinical trial
Predicting the Post-dialysis Rebound of β2-microglobulin
NCT07713680 is registered in ClinicalTrials.gov with East and North Hertfordshire NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting the Post-dialysis Rebound of β2-microglobulin
- Lead sponsor
- East and North Hertfordshire NHS Trust
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 24, 2026
- Completion date
- August 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal disease, end stage